AVROBIO
IPO News: Avrobio Inc. Prices 4.4mm Share IPO at $19 , $1 above the $16.00 - $18.00 Marketing Range
AVROBIO

Avrobio Inc.

NASDAQ: AVRO

Initial Filing Date: 05/25/18

Launch Date: 06/11/18

Pricing Date: 06/20/18

IPO Price: $19.00

Price Range: $16.00 - $18.00

Shares Offered (Pre-Shoe | mm): 4.4

Primary Shares (mm): 4.4

Secondary Shares (mm): 0

Amount Offered (mm): $83.8

% Secondary: 0.0%

Shares Outstanding (mm): 22.3

Market Value at Pricing (mm): $424.0

Offering as % of Market Value: 19.8%

Bookrunners: Morgan Stanley | Cowen | Wells Fargo Securities | Wedbush

Major Holders: Atlas Venture Funds | Clarus Life Sciences | SV Life Sciences | Citadel | Cormorant

Industry: Healthcare

Description: Avrobio is a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.